Some patients remain unwell for months after “recovering” from the acute COVID-19. They
develop persistent fatigue, cognitive problems, headaches, disrupted sleep, myalgias and …

Introduction Drug repositioning is a strategy to identify a new therapeutic indication for
molecules that have been approved for other conditions, aiming to speed up the traditional …

Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV-2) infection triggers various
events from molecular to tissue level, which in turn is given by the intrinsic characteristics of …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of the
COVID-19 disease, is a highly infectious and transmissible viral pathogen that continues to …

Abstract SARS‐CoV‐2, the etiological agent of COVID-19, is devoid of any metabolic
capacity; therefore, it is critical for the viral pathogen to hijack host cellular metabolic …

With COVID-19 becoming endemic, there is a continuing need to find biomarkers
characterizing the disease and aiding in patient stratification. We studied the relation …

COVID-19, caused by the SARS-CoV-2 coronavirus, emerged as a global pandemic in late
2019, resulting in significant global public health challenges. The emerging evidence …

Murburn concept constitutes the thesis that diffusible reactive species or DRS are
obligatorily involved in routine metabolic and physiological activities. Murzymes are defined …

Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), a novel coronavirus,
causes coronavirus disease 2019 (COVID‐19) which led to neurological damage and …

Mitochondria are multifaceted and dynamic organelles regulating various important cellular
processes from signal transduction to determining cell fate. As dynamic properties of …